Grifols (GRFS) Equity Income (2010 - 2020)

Grifols (GRFS) posted Equity Income of -$6.0 million for Q1 2020, up 70.81% quarter-over-quarter from -$20.6 million in Q4 2019, and up 11.9% year-on-year from -$5.4 million in Q2 2019.

Grifols (GRFS) Equity Income (2010 - 2020) Analysis & Trends

Grifols (GRFS) has reported Equity Income for 9 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2020.

  • Equity Income for Q1 2020 came in at -$6.0 million, up 11.9% year-over-year; the trailing twelve-month figure through Mar 2020 was -$42.5 million (down 62.04% YoY), and the FY2023 annual result was -$992016.6, up 34.39% from the prior year.
  • Equity Income was -$6.0 million for Q1 2020 at Grifols, up from -$20.6 million in the prior quarter.
  • Over five years, Equity Income peaked at -$2.5 million in Q1 2018 and troughed at -$20.6 million in Q4 2019.
  • Average Equity Income over 4 years is -$8.1 million, with a median of -$6.8 million recorded in 2019.
  • Year-over-year, Equity Income grew 27.69% in 2018 and slumped 169.62% in 2019.
  • Over 4 years, Equity Income stood at -$7.8 million in 2017, then decreased by 15.98% to -$9.1 million in 2018, then slumped by 127.41% to -$20.6 million in 2019, then surged by 70.81% to -$6.0 million in 2020.
  • Per Business Quant data, the three most recent Equity Income figures were -$6.0 million in Q1 2020, -$20.6 million in Q4 2019, and -$6.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 12.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -3.00 Mn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -6.02 Mn
Dec 31, 2019 -20.62 Mn
Mar 31, 2019 -6.83 Mn
Dec 31, 2018 -9.07 Mn
Mar 31, 2018 -2.53 Mn
Dec 31, 2017 -7.82 Mn
Mar 31, 2017 -3.50 Mn
Dec 31, 2015 -5.13 Mn
Sep 30, 2015 2.47 Mn
Jun 30, 2015 1,180.29
Mar 31, 2015 -355,897.24
Dec 31, 2014 4.56 Mn
Sep 30, 2014 674,264.05
Jun 30, 2014 2,555.80
Mar 31, 2014 2.17 Mn
Dec 31, 2013 -593,435.05
Sep 30, 2013 -381,611.12
Jun 30, 2013 1.36 Mn
Mar 31, 2013 356,495.00
Dec 31, 2012 333,301.45